Holen Sie sich die Stockscreener-App
75.26
2.90%
2.12
Handel nachbörslich:
74.97
-0.29
-0.39%
Henry Schein Inc Aktie (HSIC) Neueste Nachrichten
United States Personal Protective Equipment (Gowns, Masks, Face Shields and Others) Market Outlook to 2033 - GlobeNewswire Inc.
Henry Schein, Inc. $HSIC Shares Sold by Strs Ohio - MarketBeat
Henry Schein (BIT:1HSIC) Price Target Decreased by 12.37% to 65.12 - Nasdaq
What Henry Schein (HSIC)'s Activist-Backed Governance Shift and CEO Transition Means For Shareholders - Yahoo Finance
Greenlight Capital Backs Henry Schein As Governance Shifts Target Margins - Yahoo Finance
Assessing Henry Schein’s Valuation After Greenlight Capital’s Push For Operational Improvements - Sahm
How Henry Schein Inc. (HSIC) Affects Rotational Strategy Timing - Stock Traders Daily
Does Henry Schein (HSIC) Have Potential for Margin Improvement and Increased Shareholder Value? - Insider Monkey
Henry Schein, Inc. $HSIC Holdings Lowered by Universal Beteiligungs und Servicegesellschaft mbH - MarketBeat
Briefly: NCPA, Henry Schein Announce New Executive Leaders - HME Business
Analyst Downgrade: Will Henry Schein Inc. benefit from green energy policiesEarnings Beat & Expert Approved Trade Ideas - baoquankhu1.vn
Henry Schein Schedules Q4 2025 Earnings Call - Dentistry Today
Analysts Offer Insights on Healthcare Companies: Cardinal Health (CAH), Agios Pharma (AGIO) and Henry Schein (HSIC) - The Globe and Mail
Henry Schein to Webcast Fourth Quarter 2025 Conference Call on Tuesday, February 24, 2026, at 8:00 A.M. ET - BioSpace
How Investors Are Reacting To Henry Schein (HSIC) New CEO Pick And Exclusive CitoCBC Deal - simplywall.st
Henry Schein Shares Consolidate as Technical and Fundamental Catalysts Align - AD HOC NEWS
Henry Schein Inc. Stock Outperforms Competitors On Strong Trading Day - 富途牛牛
Dilation Capital Management LP Invests $5.11 Million in Henry Schein, Inc. $HSIC - MarketBeat
Henry Schein Names Frederick M. Lowery as Chief Executive Officer - Zenopa
Henry Schein, Inc. (NASDAQ:HSIC) Given Consensus Recommendation of "Hold" by Brokerages - MarketBeat
Henry Schein Inc. Stock Underperforms Tuesday When Compared To Competitors - 富途资讯
The Truth About Henry Schein Inc: Why Wall Street Is Watching (But TikTok Barely Cares…Yet) - AD HOC NEWS
Mizuho Adjusts Price Target on Henry Schein to $81 From $74, Maintains Neutral Rating - marketscreener.com
Palmetto Grain Brokerage - Palmetto Grain Brokerage
Here's What to Expect From Henry Schein's Next Earnings Report - Yahoo Finance
Analysts Are Bullish on These Healthcare Stocks: Henry Schein (HSIC), Boston Scientific (BSX) - The Globe and Mail
Mixed Strategic Drivers Led Upslope Capital Management to Pick Henry Schein (HSIC) - Insider Monkey
Tetratherix executes global distribution & supply agreement with Henry Schein - marketscreener.com
Tetratherix Executes Global Distribution & Supply Agreement With Henry Schein - TradingView — Track All Markets
Newly listed biotech Tetratherix secures global distribution deal with US giant Henry Schein - Business News Australia
Australia's Tetratherix hits four-week high on supply deal with Henry Schein - TradingView — Track All Markets
Henry Schein (NASDAQ:HSIC) Stock Passes Above Two Hundred Day Moving AverageTime to Sell? - MarketBeat
Henry Schein names new CEO - DrBicuspid.com
Henry Schein (HSIC) Valuation Check After Exclusive CitoCBC Distribution Agreement - Yahoo Finance
Henry Schein inks exclusive U.S. distribution deal for CLIA-waived CBC system - Medical Economics
Henry Schein enters distribution agreement for CytoChip's CLIA-waived hematology analyzer - marketscreener.com
Henry Schein Enters Distribution Agreement For CytoChip’S CLIA-Waived Hematology Analyzer - TradingView — Track All Markets
Henry Schein Agrees to Distribute CytoChip's CitoCBC system - marketscreener.com
Henry Schein (HSIC) Partners with CytoChip for Exclusive Distrib - GuruFocus
Henry Schein to distribute FDA-cleared blood test system nationwide - Investing.com
Henry Schein to distribute FDA-cleared blood test system nationwide By Investing.com - Investing.com South Africa
Henry Schein Enters Exclusive Distribution Agreement for CytoChip’s CLIA-Waived Hematology Analyzer - joplinglobe.com
Henry Schein Enters Exclusive Distribution Agreement for CytoChip's CLIA-Waived Hematology Analyzer - Quantisnow
3 Reasons to Sell HSIC and 1 Stock to Buy Instead - Yahoo Finance
Henry Schein names a new CEO - Digital Commerce 360
JPM26: Henry Schein focuses on high-margin, high-growth business as new CEO announced - Yahoo Finance
Henry Schein extends private placement facilities to 2028 - MSN
Why Henry Schein (HSIC) is a Top Value Stock for the Long-Term - sharewise.com
Henry Schein Seeks M&A Opportunities - marketscreener.com
Henry Schein Taps Former Thermo Fisher Exec as New CEO - Modern Distribution Management
Will Henry Schein’s (HSIC) New External CEO and Governance Shift Reframe Its Leadership Narrative? - simplywall.st
Henry Schein Names Thermo Fisher Exec Fred Lowery as CEO - Medical Product Outsourcing
Frederick Lowery named new CEO of Henry Schein, effective March 2026 - Investing.com Nigeria
Henry Schein appoints Frederick Lowery as CEO - MSN
Leadership transition at Henry Schein: Frederick M. Lowery to take over as CEO - Dental Tribune US
Henry Schein names Frederick M. Lowery as new CEO - newsday.com
9.59%
0.28%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):